CR GROUP L.P. received a stock award from T2 BIOSYSTEMS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 4 awards
Filed: 7/6/2023ACC: 0001209191-23-041679
+48.35M
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
4
Total transactions
48.35M acquired
Non-Derivative Transactions4
Common Stock
Indirect
Shares
+19.33M
Price / share
—
Trade value
—
% of position
New position
7/3/2023
0.00→19.33M
Common Stock
Indirect
Shares
+12.04M
Price / share
—
Trade value
—
% of position
New position
7/3/2023
0.00→12.04M
Common Stock
Indirect
Shares
+3.87M
Price / share
—
Trade value
—
% of position
New position
7/3/2023
0.00→3.87M
Common Stock
Indirect
Shares
+13.11M
Price / share
—
Trade value
—
% of position
New position
7/3/2023
0.00→13.11M
Total
Net shares
+48.35M
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 7/3/2023 | A · Award | +19.33M | — | — | New position | 0.00 | 19.33M |
| Common Stock Indirect | 7/3/2023 | A · Award | +12.04M | — | — | New position | 0.00 | 12.04M |
| Common Stock Indirect | 7/3/2023 | A · Award | +3.87M | — | — | New position | 0.00 | 3.87M |
| Common Stock Indirect | 7/3/2023 | A · Award | +13.11M | — | — | New position | 0.00 | 13.11M |
| Total | +48.35M | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported